Research Article

Identification of a Novel PPAR Signature for Predicting Prognosis, Immune Microenvironment, and Chemotherapy Response in Bladder Cancer

Figure 8

The correlation between the risk scores and clinicopathological factors. (a) Heatmap showed the relative expression of the risk score in BLCA patients at various clinical features, including age, gender, tumor grade, TNM stage, T stage, and N stage. ; (b) boxplot showed the relative expression of the risk score in BLCA patients at subgroups stratified by age, gender, tumor grade, TNM stage, T stage, and N stage.
(a)
(b)